Alexion Pharma (ALXN) Receives FDA Form 483 for Smithfield, RI, Facility
Tweet Send to a Friend
Alexion Pharma (NASDAQ: ALXN) disclosed the following on Monday:Item 8.01 Other Events.The U.S. Food and Drug Administration ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
